Terminated PHASE3 INTERVENTIONAL 2-arm NCT00515736

Impact Of Antioxidant Micronutrients On Intensive Care Unit (ICU) Outcome (Etude-AOX)

Influence Of Early Antioxidant Supplements On Clinical Evolution And Organ Function In Critically Ill Cardiac Surgery, Major Trauma And Subarachnoid Hemorrhage Patients

Sponsor: Centre Hospitalier Universitaire Vaudois

Conditions Cardiac Surgery Critically Ill Patients Subarachnoid Hemorrhage Trauma

Interventions Placebo Selenium (Se), Zinc (Zn), Vitamin C, Vitamin B1, Vitamin E

Updated 5 times since 2017 Last updated: Jul 29, 2010 Started: Jan 31, 2003 Primary completion: Dec 31, 2005 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

enrollment was completed

Other terminated trials from Centre Hospitalier Universitaire Vaudois

See all terminations from Centre Hospitalier Universitaire Vaudois

Other Cardiac Surgery trials with similar outcome

Browse all Cardiac Surgery trials

This PHASE3 trial investigates Cardiac Surgery and Critically Ill Patients and is currently terminated or withdrawn. Centre Hospitalier Universitaire Vaudois leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire Vaudois
Fresenius Kabi

Data source: Centre Hospitalier Universitaire Vaudois

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lausanne, Switzerland